Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: Publication of the critical appraisal methodology

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Inotai, András ^a   Pékli, Márta ^b   Jóna, Gabriella ^b   Nagy, Orsolya ^b   Remák, Edit ^c   Kaló, Zoltán ^d,e  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Organizational Development in Healthcare and Medicines   (Hungary)

^c United BioSource Corporation   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^e Syreon Research Institute   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CHECKLIST; COST; COST BENEFIT ANALYSIS; DECISION TREE; EASTERN EUROPE; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HUMAN; HUNGARY; METHODOLOGY; PHARMACEUTICS; PROBABILITY; QUESTIONNAIRE; REIMBURSEMENT; REVIEW; STANDARD;

CHECKLIST; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DECISION TREES; EUROPE, EASTERN; EVIDENCE-BASED MEDICINE; HEALTH PLAN IMPLEMENTATION; HUMANS; HUNGARY; MARKOV CHAINS; QUESTIONNAIRES; REIMBURSEMENT MECHANISMS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TECHNOLOGY, PHARMACEUTICAL;

EID: 84866518415     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-332     Document Type: Article

References (28)

1. Slovakia health system review. Szalay T, Pazitn P, Szalayová A, Frisová S, Morvay K, Petrovic M, van Ginneken E, Health Syst Transit 2011 13 1 174 22551527
2. OECD, Health at a Glance 2011 http://www.oecd.org/dataoecd/6/28/49105858. pdf Accessed [14 May 2012]
3. Risk sharing methods in middle income countries. Inotai A, Kalá Z, Acta Pharm Hung 2012 82 43 52 Hungarian 22570986
4. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Tantivess S, Teerawattananon Y, Mills A, Pharmacoeconomics 2009 27 931 945 10.2165/11314710-000000000-00000 19888793
5. HTA in central and Eastern Europe: current status, challenges and opportunities. Sorenson C, Kanavos P, Karamalis M, Journal of Medical Device Regulation 2009 6 34 45
6. Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries. Kalá Z, Landa K, Doleal T, Voká Z, Eur J Cancer Care 2012
7. Economic evaluation for devices and drugs-same or different? Drummond M, Griffin A, Tarricone R, Value Health 2009 12 402 404 10.1111/j.1524-4733.2008. 00476-1.x 19138306
8. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) General Methods Version 3.0 of 27.05. 2008, Germany 2011 https://www.iqwig.de/download/IQWiG-General-methods-V-3-0.pdf Accessed [11 June 2011] 23019439
9. National Institute for Health and Clinical Excellence (NICE), United Kingdom: Guide to the methods of technology appraisal ISBN: 1-84629-741-9. Issue date June 2008 2011 http://www.nice.org.uk/media/B52/A7/ TAMethodsGuideUpdatedJune2008.pdf Accessed [11 June 2011]
10. National Institute for Health and Clinical Excellence (NICE), United Kingdom: Diagnostics Assessment Programme manual 2012 http://www.nice.org.uk/ media/A0B/97/DAPManualFINAL.pdf Accessed [14 May 2012]
11. National Institute for Health and Clinical Excellence (NICE), United Kingdom: Medical Technologies Evaluation Programme. Methods guide 2012 http://www.nice.org.uk/media/3A6/09/ MedicalTechnologiesEvaluationProgrammeMethodsGuideMarch2012.pdf Accessed [14 May 2012]
12. Economic analysis in randomised control trials. Adams ME, McCall NT, Gray DT, Orza MJ, Chalmers TC, Med Care 1992 30 231 238 10.1097/00005650-199203000- 00005 1538611
13. Development and validation of a grading system for the quality of cost-effectiveness studies. Chiou CF, Hay JW, Wallace JF, Bloom BS, Neumann PJ, Sullivan SD, Yu HT, Keeler EB, Henning JM, Ofman JJ, Med Care 2003 41 32 44 10.1097/00005650-200301000-00007 12544542
14. Criteria list for assessment of methodological quality of economic evaluations: Consensus on health economic criteria. Evers S, Goossens M, de Vet H, van Tulder M, Ament A, Int J Technol Assess Health Care 2005 21 240 245 15921065
15. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. Drummond MF, Jefferson TO, BMJ 1996 313 275 283 10.1136/bmj.313.7052.275 8704542
16. Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards. Szende A, Mogyorásy Z, Muszbek N, Nagy J, Pallos G, Dázsa C, Eur J Health Econom 2002 3 196 206 10.1007/s10198-002-0109-6
17. Using economic evaluations to make formulary coverage decisions. So much for guidelines. Anis AH, Gagnon Y, Pharmacoeconomics 2000 18 55 62 10.2165/00019053-200018010-00006 11010604
18. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean Region. Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Martí SG, Pharmacoeconomics 2009 27 919 929 10.2165/11313670-000000000-00000 19888792
19. Examining the quality of health economic analyses submitted to the Pharmaceutical Benefits Board in Sweden. Ramsberg J, Odeberg S, Engström A, Lundin D, Eur J Health Econom 2004 49 351 356
20. Public Health Resource Unit, United Kingdom: CASP 10 questions to help you make sense of economic evaluations 2010 [ http://www.sph.nhs.uk/sph-files/ Economic%20Evaluations%2010%20Questions.pdf ]. Accessed [11 October 2010]
21. Health Economists Study Group, How the group works? Website of the Health Economists Study Group 2012 http://www.hesg.org.uk/information.php Accessed [14 May 2012]
22. Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity. Gerkens S, Crott R, Cleemput I, Thissen JP, Closon MC, Horsmans Y, Beguin C, Int J Technol Assess Health Care 2008 24 318 325 18601800
23. Developing a scoring system to quality assess economic evaluations. Gonzalez-Perez JG, Eur J Health Econom 2002 3 131 136 10.1007/s10198-002-0100-2
24. Drummond MF, OBrien BJ, Stoddart LG, Torrance GW, Critical assessment of economic evaluation. Methods for economic evaluation of health care programs Oxford University Press, New York 2 1997
25. Health and economic outcomes modeling practices: a suggested framework. Halpern MT, Luce BR, Brown RE, Geneste B, Value Health 1998 1 131 147 10.1046/j.1524-4733.1998.120131.x 16674361
26. EUnetHTA JA WP5: Relative Effectiveness Assessment (REA) of Pharmaceuticals 2012 http://www.eunethta.eu/upload/WP5/Link1.pdf Accessed [14 May 2012]
27. Health economic evaluations using decision analytic modeling. Principles and practicesUtilization of a checklist to their development and appraisal. Soto J, Int J Technol Assess Health Care 2002 18 94 111 11987445
28. Can economic evaluations be made more transferable? Boulenger S, Nixon J, Drummond M, Ulmann P, Rice S, de Pouvourville G, Eur J Health Econom 2005 6 334 346 10.1007/s10198-005-0322-1